Genomind

Genomind is a mental health biotechnology and digital services company that provides innovative solutions for personalized mental health and wellness through genetic testing. The Genomind® Professional PGx Express™ is an industry-leading pharmacogenetic test for prescription medications, equipping mental health professionals with the tools needed to determine personalized treatment plans for patients more quickly. We offer more comprehensive gene-guided insights, superior speed and accuracy, cutting-edge digital tools, and on-demand or scheduled consultations with PhD and PharmD experts, enabling your provider to deliver the highest quality of psychiatric care. This test is available only through clinician order. The Genomind® Mental Health Map™ is the first-ever direct-to-consumer genetic test specifically designed for mental health. It delivers powerful new insights and actionable information through 7 Core Genetic Mental Health Capabilities™ by analyzing 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. A free consultation is included to help individuals better utilize their results.